Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6332150B2 - - Google Patents
[go: Go Back, main page]

JPS6332150B2 - - Google Patents

Info

Publication number
JPS6332150B2
JPS6332150B2 JP20987181A JP20987181A JPS6332150B2 JP S6332150 B2 JPS6332150 B2 JP S6332150B2 JP 20987181 A JP20987181 A JP 20987181A JP 20987181 A JP20987181 A JP 20987181A JP S6332150 B2 JPS6332150 B2 JP S6332150B2
Authority
JP
Japan
Prior art keywords
particles
solution
carrier
gelatin
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP20987181A
Other languages
Japanese (ja)
Other versions
JPS58113757A (en
Inventor
Mikio Ikeda
Takayuki Tomizawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Original Assignee
Fujirebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Inc filed Critical Fujirebio Inc
Priority to JP20987181A priority Critical patent/JPS58113757A/en
Priority to EP19820301235 priority patent/EP0062968B2/en
Publication of JPS58113757A publication Critical patent/JPS58113757A/en
Publication of JPS6332150B2 publication Critical patent/JPS6332150B2/ja
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548Carbohydrates, e.g. dextran
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03CPHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C1/00Photosensitive materials
    • G03C1/005Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
    • G03C1/04Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with macromolecular additives; with layer-forming substances
    • G03C1/047Proteins, e.g. gelatine derivatives; Hydrolysis or extraction products of proteins
    • G03C2001/0471Isoelectric point of gelatine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Description

【発明の詳細な説明】 本発明は抗原とか抗体の感作あるいは酵素の固
定などに広く利用しうる新規な人工担体の製法の
改良に関する。抗原、抗体反応を利用する臨床検
査等の分野において、抗原または抗体をある適当
な大きさの粒子を担体としてそれに吸着もしくは
結合させ、それぞれに対応する抗体または抗原の
存在によつてこの感作された担体の凝集を起させ
る方法は間接受身凝集反応と呼ばれている。そし
て、この間接受身凝集反応は被検液中の抗体や抗
原を高感度に検出できるので、いろいろの疾患の
血清学的診断や血液学的診断に広く用いれてい
る。 この反応に用いられる担体としては、ポリスチ
レンラテツクス、カオリン、炭末などの非生物学
的粒子と、動物赤血球、細菌菌体のような生物学
的粒子とがある。一般に非生物学的粒子の担体
は、化学的に安定で、それ自身抗原活性を有しな
いなどの利点はあるが、抗原あるいは抗体が密に
吸着されにくいという欠点がある。たとえば、保
存のために凍結乾燥すると抗原や抗体が担体から
遊離してしまうのである。そのために、やむなく
液体中で冷暗所に保存するという手段がとられて
いるが、その結果長期間保存することができな
い。また、非生物学的担体のうち、炭末とカオリ
ンは一定の大きさの粒子を選出することが困難で
あり、ポリスチレンラテツクスは反応の媒質とし
て望ましい中性域では非特異凝集である自然凝集
をおこす危険がある。 一方、生物学的担体である動物赤血球や細菌菌
体はそれぞれの大きさが一定であるという利点は
あるものの、生物の種類によつて粒子の大きさは
定まつており、目的に応じた任意の大きさの粒子
を得ることはできない。たとえば、動物赤血球は
大きさの一定した最も入手しやすい担体である
が、血球表面に固有の抗原を有しており、抗体と
の間で非特異凝集反応である交差反応を起こして
目的とする凝集反応に誤まりを与える可能性があ
る。さらに、赤血球の生物学的、化学的および物
理的特性値が動物の個体間でばらついてしまつて
常に一定品質の血球を入手することが難しいとい
う欠点がある。 本発明者らはこれらの欠点のないすぐれた担体
を開発すべく種々検討の結果、ゼラチン、水溶性
多糖類、およびポリメタリン酸ナトリウムを含
み、水とアルコール等の混合物を溶媒とする溶液
を撹拌下でPH調整することによつて粒子を析出さ
せ、この粒子をアルデヒド系架橋剤で処理して不
溶化すれば、従来の欠点を尽く解消したすぐれた
担体が得られることを見出し、この内容を既に特
許出願した(特開昭57−153658号)。そして、そ
の後アルコール等の親水性有機溶媒を用いなくと
も人工担体が好収率で得られることを見出してこ
の内容も特許出願した(特開昭57−160465号)。
しかしなが、いずれの方法においても生成した粒
子の凝集を防止するために界面活性剤を添加して
いた。本発明者らはさらに研究を進めた結果、溶
媒が水のみで親水性有機溶媒を用いない場合であ
つても酸の添加によつて粒子が生成したのちに速
かに冷却すれば界面活性剤を添加しなくとも界面
活性剤を添加した場合に匹敵する好収率で担体粒
子が得られることを見出し、これに基づいて本発
明を完成するに到つた。 すなわち本発明は、ゼラチン、水溶性多糖類、
およびポリメタリン酸ナトリウムを含み、温度が
ゼラチンのゲル化温度以上である水溶液を撹拌し
つつ酸を加えてPH2.5〜6.0に調整し、その後アル
デヒド系架橋剤を作用せしめて不溶化する人工担
体の生産法において、前記酸の添加によつて粒子
が生成したのちこの粒子分散液を10℃以下に冷却
し、10℃以下の温度で前記架橋剤を作用せしめる
ことを特徴とする人工担体の生産法に関するもの
である。 本発明に使用するゼラチンは通常は市販品をそ
のまま用いればよい。市販品のなかでは酸性ゼラ
チンが好ましい。 水溶性多糖類は増粘剤または糊料として使用し
うるものであり、多糖類の誘導体および塩も含ま
れる。例としては、アラビアゴム、カルボキシメ
チルセルロース、アルギン酸ナトリウム、寒天、
カラゲーナンなどを挙げることができるが、特に
アルビアゴムが好適である。 ポリメタリン酸ナトリウムは化学式(NaPO3
oで表わされる物質であり、たとえば四メタリン
酸ナトリウム、ヘキサメタリン酸ナトリウムの如
きものである。 そのほかのものとしては、担体を着色する場合
には、着色剤を粒子形成前に溶液に加えておくの
がよい。着色を必要とする例としては、本発明品
を間接受身凝集反応の担体として用いる場合を挙
げることができる。すなわち、本発明品は通常は
無色不透明であるところから、これを着色するこ
とによつて凝集像の判定を容易にすることができ
る。着色剤としては、たとえば食用赤色3号、ロ
ーダミン、ローズベンガル、ポンソー3R、ボル
ドーS、フクシン、エオシン、およびニユートラ
ルレツドなどの赤色色素、あるいはクリスタルバ
イオレツト、トルイジンブルーおよびメチレンブ
ルーなどの青色色素等を用いうる。しかしなら
が、リアクテイブレツド、ダイレクト・ブルーな
どの反応性染料で着色すれば色落ちしないことか
ら、反応性染料が特に好適である着色剤以外にも
目的に応じ種々の物質を添加してもよいことはい
うまでもない。 PH調整前の溶液におけるこれら各物質の濃度と
しては、ゼラチン0.01〜2%程度、好ましくは
0.05〜1.0%程度、そして水溶性多糖類0.01〜2%
程度、好ましくは0.05〜1.0%程度である。ポリ
メタリン酸ナトリウムはゼラチン乾燥重量の0.5
〜20%程度を含有させるようにするのがよい。各
物質はこれらの濃度範囲において、所望の粒子の
粒径および物性に応じて適宜定めればよい。着色
剤を添加する場合には、通常は0.005〜0.5%程度
であるが、反応性染料を用いればゼラチン乾燥重
量の1〜5%程度で足りる。 このような溶液を調整する過程は問うところで
はなく、例えば各々を温水に溶解してから混合し
てもよく、各々を一緒に溶解してもよい。しかし
ながら、各物質の溶解を容易にするために親水性
有機溶媒はあとから加えるのがよく、また水溶性
多糖類には不溶成分も少量含まれていることが多
いところから、別途に溶解して添加するのがよ
い。一方、ゼラチンは等電点以下のPHでは水溶性
多糖類と反応して白濁を生ずるので酸性ゼラチン
を用いる場合にはアルカリを加えて溶液のPHを少
なくともその付近にまで高めておくのがよい。し
かしながら、この白濁は生じた後でもアルカリを
添加することによつて消すことができる。いずれ
にせよ、溶液は酸の添加を開始するまえには白濁
のない状態にしておかなければならない。 溶液の温度はゼラチンのゲル化温度以上でなけ
ればならない。この温度はゼラチンの濃度等によ
つて異なるが通例25〜30℃程度である。良好な粒
子形成の観点から特に35〜50℃程度がよい。 次に、この溶液を撹拌しながら酸を加えてPH
2.5〜6.0に調整する。この工程は粒子を生成させ
るところである。均一な粒子を形成させるため
に、35〜50℃に加温を続け、適度に撹拌しながら
酸を滴下していくのがよい。PH2.5〜6.0の範囲に
おける至適のPHは原料溶液の組成および目的とす
る粒径によつて異なるので予め実験を行なつて定
めるのがよい。たとえば得られた粒子を抗原感作
用担体に用いる場合には2〜10μ程度の粒径にす
るのがよく、その場合至適のPHは4.0〜5.5の範囲
にある。このPH調整に使用する酸は特に限定され
るものではなく無機酸でも有機酸でもよいが、な
るべくおだやかなものがよく、たとえば酢酸など
が好適である。 本工程で生成した粒子は系の温度をゼラチンの
ゲル化温度以下に下げても消失しないので母液と
の平衡関係はない。また、粒子はほとんどの場合
負に帯電しており、その表面には溶液中の陽イオ
ンが配向していていわゆる電気二重層を形成して
いる。そして、このことが粒子の安定な分散を促
しているのである。 本発明においては酸を添加して粒子を生成させ
たのちに粒子生成液をゲル化温度以下に冷却し、
そのことによつて界面活性剤の添加を不要にした
ところに特徴がある。冷却は酸の添加終了後速か
に行なうのがよい。添加終了後室温に放置してお
くと粒子が互いに衝突して凝集がはじまつてしま
う。温度はゲル化温度以下であるが、5℃以下に
することが好ましい。粒子生成後は粒子をアルデ
ヒド系架橋剤で不溶化するのであるが、その間も
粒子分散液をゲル化温度以下に保つ必要がある。
但し、粒子の再分散が容易になる程度に不溶化が
進行するまでこの温度に保てばよい。アルデヒド
系架橋剤の添加量はゼラチン乾燥重量の0.1〜200
%程度であり、添加後は一夜程度放置して架橋反
応を充分に行なわせる。架橋剤の例としては、グ
ルタルアルデヒド、ホルムアルデヒド、グリオキ
ザール、クロトンアルデヒド、アクロレイン、ア
セトアルデヒドなどを挙げることができるが、特
にグルタルアルデヒドが好適である。 アルデヒド系架橋剤で処理後は粒子を遠心分離
等で回収して洗浄する。洗浄は0.001〜0.01%程
度の陰イオン系界面活性剤水溶液または0.01〜
0.1%の非イオン系界面活性剤水溶液を用いて2
〜3回行なえばよい。 このようにして得られた担体を種々の用途に供
すればよいが、架橋が不充分な場合には塩類溶液
中で膨潤することがある。そこでこのような用途
に用いる場合にはアルデヒド系架橋剤で処理して
膨潤を防止するのがよい。例えば、抗原を感作す
る場合にはリン酸緩衝液中で行なうので、赤血球
を固定化する条件でホルマリン処理する。この処
理によつて膨潤を防止するとともにホルマリンの
殺菌効果によつて長期間の保存に耐える担体が得
られる。 本発明の担体は抗原、抗体、酵素などを巾広く
固定することができる。たとえば、抗原とか抗体
を感作する場合には動物赤血球を担体として行な
う常法に準じて行えばよい。 本発明の担体は間接受身凝集反応の担体として
従来最もすぐれているとされていた動物赤血球と
同等の性能を有し、さらに化学的、物理的に均質
かつ安定であり、抗原活性がなく任意の粒径のも
のを容易かつ安価に大量生産できるなど動物赤血
球にない幾多の利点を有するものである。そして
本発明は先願発明に対し有機溶剤と界面活性剤の
2つの使用を排除したものであり、本発明によつ
てこのようにすぐれた性質を有する人工担体を容
易にかつ簡便に製造することができる。有機溶剤
を不要にすることによつて製造設備を簡略化しか
つ操作を容易にしており、また、この方法で得ら
れた担体は例えば界面活性剤の存在を嫌うような
用途にも使用できる。 以下、実施例及び担体の使用例を示す。なお、
本明細書において特に記載がなければ%は重量%
を表わしている。 実施例 1 等電点がPH9であるゼラチン4gを40℃の温水
に100mlになるように溶解し、10%の水酸化ナト
リウム溶液でPH9に調整した。アラビアゴム4g
を100mlになるように水に溶解し、不溶物を別
した後40℃に加温した。 ゼラチン溶液50mlとアラビアゴム溶液50mlを混
合し、これに40℃の蒸溜水300ml、10%ヘキサメ
タリン酸ナトリウム溶液1.6ml、および1%ダイ
レクトブルー溶液6mlを加えた。 次いで、この溶液を40℃に保ち、撹拌しながら
10容量%酢酸溶液を滴下してPH4.8に調整し、粒
子を生成させた。 粒子分散液を氷冷して5℃にしてからグルター
ルアルデヒド1.3gを加え、よく撹拌後この温度で
一夜静置した。それからこの粒子分散液を
2000rpmで10分間遠心分離して粒子をペレツトと
して回収した。この粒子を粒子濃度が5%になる
ように4容量%のホルマリン溶液に分散し、5℃
で1週間静置した。 本例で得られた粒子は7.5gであり、その75%が
2〜3.2μの範囲にあつた。 実施例 2 下記の点を除いて実施例1と同様にして担体粒
子を調製した。 すなわち、アラビアゴム4gのかわりにカルボ
キシメチルセルロース1gを用い、ゼラチン、10
%ヘキサメタリン酸ナトリウム溶液、1%ダイレ
クトブルー溶液、およびグルタルアルデヒドの添
加量をいずれも4分の1にした。また、PHも4.8
から4.2にした。 このようにして得られた担体粒子は5.6gであ
り、その90%が1〜2μの範囲にあつた。 実施例 3 下記の点を除いて実施例1と同様にして担体粒
子を調製した。 すなわち、ゼラチン溶液を50mlから40mlにし、
アラビアゴム溶液を50mlから60mlに変えた。それ
から、10%ヘキサメタリン酸ナトリウム溶液を
1.6mlから1.2mlに、1%ダイレクトブルー6mlを
4.8mlに、そしてグルタルアルデヒドを1.3gから
1.0gにそれぞれ変えた。また、酢酸の滴下終了PH
を4.2とした。 このようにして得られた担体粒子は10.4gであ
り、その90%が1〜2μの範囲にあつた。 実施例 4 下記の点を除いて実施例1と同様にして担体粒
子を調製した。 すなわち、ゼラチン溶液を50mlから60mlにし、
アラビアゴム溶液を50mlから40mlに変えた。それ
から、10%ヘキサメタリン酸ナトリウム溶液を
1.6mlから2mlに、1%ダイレクトブルー6mlを
7.2mlに、そしてグルタルアルデヒドを1.3gから
1.8gにそれぞれ変えた。また、酢酸の滴下終了PH
を4.7とした。 このようにして得られた担体粒子は11.2gであ
り、その70%が6〜9μの範囲にあつた。 使用例 実施例1で得られた担体粒子を濃度が5%にな
るようにPH7.2のリン酸塩緩衝生理食塩水(以下、
PBSと略記する。)に分散し、その20mlを5ppm
のタンニン酸を含むPH7.2のPBS20mlと混合した。 混合液を37℃で15分間加温後遠心分離して生理
食塩水で充分洗浄してから5%になるようにPH
6.4のPBSに分散し全量を20mlとした。一方、PH
6.4のPBS中に浮遊させた梅毒病原体トレポネー
マ・パリーダムを超音波処理して破壊し、抗原液
とした。 タンニン酸処理粒子分散液20mlと抗原液20mlと
を混合して37℃で40分間加温した。こうして得ら
れた抗原感作粒子をPH6.4のPBSで充分に洗浄し、
粒子濃度が5%になるように19mlの分散用メデイ
ウムに分散して凍結乾燥した。 この凍結乾燥品に蒸溜水を加えて凍結乾燥前と
同容量になるように復元し、梅毒陽性血清につい
てマイクロタイタープレート法で力価を測定した
結果を下表に示す。なお、ヒツジ赤血球を担体と
した市販のTPHAキツト(富士臓品製薬(株)製)
を用いて同様に測定した結果も併せて示す。 【表】
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an improved method for producing a novel artificial carrier that can be widely used for sensitizing antigens and antibodies, immobilizing enzymes, and the like. In fields such as clinical tests that utilize antigen and antibody reactions, antigens or antibodies are adsorbed or bonded to particles of an appropriate size as carriers, and the particles are sensitized by the presence of the corresponding antibodies or antigens. The method of causing aggregation of carriers is called indirect passive agglutination reaction. Since this indirect passive agglutination reaction can detect antibodies and antigens in a sample liquid with high sensitivity, it is widely used in serological and hematological diagnosis of various diseases. Carriers used in this reaction include non-biological particles such as polystyrene latex, kaolin, and charcoal powder, and biological particles such as animal red blood cells and bacterial cells. In general, non-biological particle carriers have advantages such as being chemically stable and having no antigenic activity themselves, but have the disadvantage that antigens or antibodies are difficult to adsorb closely. For example, when freeze-drying for storage, antigens and antibodies are released from the carrier. For this reason, it is unavoidable to store it in a liquid in a cool, dark place, but as a result, it cannot be stored for a long period of time. Furthermore, among non-biological carriers, it is difficult to select particles of a certain size for charcoal powder and kaolin, and for polystyrene latex, natural aggregation occurs due to non-specific aggregation in the neutral region, which is desirable as a reaction medium. There is a risk of causing On the other hand, although animal red blood cells and bacterial cells, which are biological carriers, have the advantage of having a constant size, the particle size is fixed depending on the type of organism, and can be adjusted to suit the purpose. It is not possible to obtain particles of size . For example, animal red blood cells are the most readily available carrier with a constant size, but they have unique antigens on the surface of the blood cells, and cross-react with antibodies, which is a non-specific agglutination reaction. This may cause errors in the agglutination reaction. Furthermore, the biological, chemical, and physical properties of red blood cells vary among individual animals, making it difficult to obtain blood cells of constant quality. As a result of various studies in order to develop an excellent carrier free of these drawbacks, the present inventors prepared a solution containing gelatin, a water-soluble polysaccharide, and sodium polymetaphosphate in a mixture of water, alcohol, etc. as a solvent under stirring. We discovered that by precipitating particles by adjusting the pH with water and insolubilizing these particles by treating them with an aldehyde-based crosslinking agent, an excellent carrier that overcomes all of the drawbacks of conventional methods can be obtained.We have already patented this content. An application was filed (Japanese Patent Application Laid-Open No. 153658/1983). Later, they discovered that an artificial carrier could be obtained in good yield without using a hydrophilic organic solvent such as alcohol, and filed a patent application for this patent (Japanese Patent Laid-Open No. 160465/1983).
However, in both methods, a surfactant was added to prevent the particles produced from agglomerating. As a result of further research, the present inventors found that even when the solvent is water only and no hydrophilic organic solvent is used, if particles are formed by adding an acid and then cooled quickly, the surfactant The inventors have discovered that carrier particles can be obtained at a good yield comparable to when a surfactant is added without the addition of a surfactant, and based on this finding, the present invention has been completed. That is, the present invention provides gelatin, a water-soluble polysaccharide,
Production of an artificial carrier by adding acid to an aqueous solution containing sodium polymetaphosphate and having a temperature higher than the gelling temperature of gelatin, adjusting the pH to 2.5 to 6.0 with stirring, and then insolubilizing it by applying an aldehyde crosslinking agent. A method for producing an artificial carrier, characterized in that after particles are generated by the addition of the acid, the particle dispersion is cooled to 10°C or lower, and the crosslinking agent is allowed to act at a temperature of 10°C or lower. It is something. As the gelatin used in the present invention, commercially available gelatin may generally be used as is. Among commercially available products, acidic gelatin is preferred. Water-soluble polysaccharides can be used as thickeners or thickeners, and also include derivatives and salts of polysaccharides. Examples include gum arabic, carboxymethyl cellulose, sodium alginate, agar,
Examples include carrageenan, and gum albia is particularly preferred. Sodium polymetaphosphate has the chemical formula ( NaPO3 )
It is a substance represented by o , such as sodium tetrametaphosphate and sodium hexametaphosphate. Alternatively, if the carrier is to be colored, a coloring agent may be added to the solution before particle formation. An example where coloring is required is when the product of the present invention is used as a carrier for an indirect passive aggregation reaction. That is, since the product of the present invention is normally colorless and opaque, by coloring it, the agglomerated image can be easily determined. Examples of coloring agents include red pigments such as Food Red No. 3, Rhodamine, Rose Bengal, Ponceau 3R, Bordeaux S, Fuchsin, Eosin, and Neutral Red, or blue pigments such as Crystal Violet, Toluidine Blue, and Methylene Blue. can be used. However, if colored with reactive dyes such as Reactive Red and Direct Blue, the color will not fade, so in addition to the coloring agent for which reactive dyes are particularly suitable, various substances can be added depending on the purpose. Needless to say, this is a good thing. The concentration of each of these substances in the solution before pH adjustment is about 0.01 to 2% gelatin, preferably
About 0.05-1.0%, and water-soluble polysaccharides 0.01-2%
degree, preferably about 0.05 to 1.0%. Sodium polymetaphosphate is 0.5 of the dry weight of gelatin.
It is preferable to contain about 20%. Each substance may be appropriately determined within these concentration ranges depending on the particle size and physical properties of the desired particles. When adding a coloring agent, the amount is usually about 0.005 to 0.5%, but if a reactive dye is used, about 1 to 5% of the dry weight of gelatin is sufficient. The process for preparing such a solution is not critical; for example, each may be dissolved in warm water and then mixed, or each may be dissolved together. However, in order to facilitate the dissolution of each substance, it is best to add a hydrophilic organic solvent later, and since water-soluble polysaccharides often contain small amounts of insoluble components, they must be dissolved separately. It is good to add it. On the other hand, gelatin reacts with water-soluble polysaccharides and becomes cloudy at a pH below its isoelectric point, so when using acidic gelatin, it is advisable to add an alkali to raise the pH of the solution to at least around that point. However, even after this cloudiness occurs, it can be eliminated by adding an alkali. In any case, the solution must be free from cloudiness before starting the addition of acid. The temperature of the solution must be above the gelatin temperature. This temperature varies depending on the concentration of gelatin, etc., but is usually about 25 to 30°C. From the viewpoint of good particle formation, the temperature is preferably about 35 to 50°C. Next, add acid to this solution while stirring to make the pH
Adjust to 2.5-6.0. This step is where particles are generated. In order to form uniform particles, it is best to continue heating to 35-50°C and drop the acid while stirring moderately. The optimum PH in the range of PH2.5 to 6.0 varies depending on the composition of the raw material solution and the target particle size, so it is best to determine it in advance by conducting experiments. For example, when the obtained particles are used as an antigen-sensitizing carrier, the particle size is preferably about 2 to 10 μm, and in this case, the optimum pH is in the range of 4.0 to 5.5. The acid used for this pH adjustment is not particularly limited and may be an inorganic acid or an organic acid, but it is preferable to use one that is as mild as possible, and for example, acetic acid is preferable. The particles produced in this step do not disappear even if the temperature of the system is lowered below the gelatin temperature, so there is no equilibrium relationship with the mother liquor. In addition, most of the particles are negatively charged, and the cations in the solution are oriented on their surfaces, forming a so-called electric double layer. This also promotes stable dispersion of particles. In the present invention, after adding an acid to generate particles, the particle generation liquid is cooled to a temperature below the gelling temperature,
The feature is that this makes it unnecessary to add a surfactant. Cooling is preferably carried out quickly after the addition of acid is completed. If the mixture is left at room temperature after addition, the particles will collide with each other and agglomeration will begin. The temperature is below the gelation temperature, preferably below 5°C. After particle generation, the particles are insolubilized using an aldehyde crosslinking agent, but during this time it is necessary to maintain the particle dispersion at a temperature below the gelling temperature.
However, it is sufficient to maintain this temperature until insolubilization progresses to the extent that particles can be easily redispersed. The amount of aldehyde crosslinking agent added is 0.1 to 200 of the dry weight of gelatin.
%, and after addition, it is left to stand for about one night to allow the crosslinking reaction to occur sufficiently. Examples of the crosslinking agent include glutaraldehyde, formaldehyde, glyoxal, crotonaldehyde, acrolein, and acetaldehyde, with glutaraldehyde being particularly preferred. After treatment with an aldehyde crosslinking agent, the particles are collected by centrifugation or the like and washed. Cleaning is done with an anionic surfactant aqueous solution of about 0.001-0.01% or 0.01-0.01%.
2 using a 0.1% nonionic surfactant aqueous solution.
You only need to do this 3 times. The carrier thus obtained may be used for various purposes, but if crosslinking is insufficient, it may swell in a salt solution. Therefore, when used for such purposes, it is recommended to treat with an aldehyde crosslinking agent to prevent swelling. For example, when sensitizing an antigen, it is carried out in a phosphate buffer, so formalin treatment is performed under conditions that fix red blood cells. This treatment prevents swelling and, due to the sterilizing effect of formalin, provides a carrier that can be stored for a long period of time. The carrier of the present invention can immobilize a wide variety of antigens, antibodies, enzymes, and the like. For example, when sensitizing an antigen or antibody, a conventional method using animal red blood cells as a carrier may be used. The carrier of the present invention has performance equivalent to that of animal red blood cells, which was conventionally considered to be the best carrier for indirect passive agglutination reactions, and is chemically and physically homogeneous and stable, has no antigenic activity, and has no antigenic activity. It has many advantages over animal red blood cells, such as the ability to easily and inexpensively mass-produce particles of a certain size. The present invention eliminates the use of organic solvents and surfactants in contrast to the prior invention, and the present invention makes it possible to easily and conveniently produce an artificial carrier having such excellent properties. Can be done. By eliminating the need for organic solvents, the production equipment is simplified and operations are facilitated, and the carrier obtained by this method can also be used, for example, in applications where the presence of surfactants is undesirable. Examples and usage examples of carriers are shown below. In addition,
In this specification, unless otherwise specified, % is % by weight
It represents. Example 1 4 g of gelatin having an isoelectric point of PH9 was dissolved in 40°C warm water to a total volume of 100 ml, and the pH was adjusted to 9 with a 10% sodium hydroxide solution. 4g gum arabic
was dissolved in water to a total volume of 100 ml, and after removing insoluble matter, the mixture was heated to 40°C. 50 ml of gelatin solution and 50 ml of gum arabic solution were mixed, and to this were added 300 ml of distilled water at 40°C, 1.6 ml of 10% sodium hexametaphosphate solution, and 6 ml of 1% Direct Blue solution. This solution was then kept at 40°C and stirred.
A 10% by volume acetic acid solution was added dropwise to adjust the pH to 4.8 to generate particles. The particle dispersion was ice-cooled to 5° C., 1.3 g of glutaraldehyde was added thereto, and after thorough stirring, it was allowed to stand at this temperature overnight. Then this particle dispersion
The particles were collected as a pellet by centrifugation at 2000 rpm for 10 minutes. The particles were dispersed in a 4% by volume formalin solution so that the particle concentration was 5%, and the mixture was heated at 5°C.
It was left undisturbed for one week. The particles obtained in this example weighed 7.5 g, and 75% of them were in the range of 2 to 3.2 microns. Example 2 Carrier particles were prepared in the same manner as in Example 1 except for the following points. That is, instead of 4 g of gum arabic, use 1 g of carboxymethyl cellulose, gelatin, 10
% sodium hexametaphosphate solution, 1% Direct Blue solution, and glutaraldehyde were all reduced to one quarter. Also, the pH is 4.8
I changed it from 4.2. The carrier particles thus obtained weighed 5.6 g, 90% of which were in the 1-2 micron range. Example 3 Carrier particles were prepared in the same manner as in Example 1 except for the following points. That is, increase the gelatin solution from 50ml to 40ml,
The gum arabic solution was changed from 50ml to 60ml. Then, 10% sodium hexametaphosphate solution
From 1.6ml to 1.2ml, add 6ml of 1% Direct Blue.
to 4.8ml, and glutaraldehyde from 1.3g.
Each was changed to 1.0g. Also, the pH at the end of acetic acid addition is
was set to 4.2. The carrier particles thus obtained weighed 10.4 g, 90% of which were in the 1-2 micron range. Example 4 Carrier particles were prepared in the same manner as in Example 1 except for the following points. That is, increase the gelatin solution from 50ml to 60ml,
The gum arabic solution was changed from 50ml to 40ml. Then, 10% sodium hexametaphosphate solution
From 1.6ml to 2ml, add 6ml of 1% Direct Blue.
to 7.2ml, and glutaraldehyde from 1.3g.
I changed it to 1.8g each. Also, the pH at the end of acetic acid addition is
was set at 4.7. The carrier particles thus obtained weighed 11.2 g, 70% of which were in the 6-9μ range. Usage example The carrier particles obtained in Example 1 were added to phosphate buffered saline (hereinafter referred to as
Abbreviated as PBS. ) and 20ml of it to 5ppm
of PBS containing tannic acid at pH 7.2. After warming the mixture at 37℃ for 15 minutes, centrifuge it, wash it thoroughly with physiological saline, and adjust the pH to 5%.
6.4 in PBS to make the total volume 20 ml. On the other hand, PH
The syphilis pathogen Treponema pallidum suspended in PBS in 6.4 was destroyed by sonication and used as an antigen solution. 20 ml of the tannic acid-treated particle dispersion and 20 ml of the antigen solution were mixed and heated at 37° C. for 40 minutes. The antigen-sensitized particles thus obtained were thoroughly washed with PBS of PH6.4,
The particles were dispersed in 19 ml of dispersion medium to a particle concentration of 5% and freeze-dried. Distilled water was added to this freeze-dried product to reconstitute it to the same volume as before freeze-drying, and the titer of the syphilis-positive serum was measured using the microtiter plate method. The results are shown in the table below. In addition, a commercially available TPHA kit (manufactured by Fuji Zoshihin Pharmaceutical Co., Ltd.) using sheep red blood cells as a carrier is available.
The results of similar measurements using the same method are also shown. 【table】

Claims (1)

【特許請求の範囲】[Claims] 1 ゼラチン、水溶性多糖類、およびポリメタリ
ン酸ナトリウムを含み、温度がゼラチンのゲル化
温度以上である水溶液を、撹拌しつつ酸を加えて
PH2.5〜6.0に調整し、その後アルデヒド系架橋剤
を作用せしめて不溶化する人工担体の生産法にお
いて、前記酸の添加によつて粒子が生成したのち
この粒子分散液をゲル化温度以下に冷却し、ゲル
化温度以下の温度で前記架橋剤を作用せしめるこ
とを特徴とする人工担体の生産法。
1. An aqueous solution containing gelatin, a water-soluble polysaccharide, and sodium polymetaphosphate and having a temperature equal to or higher than the gelation temperature of gelatin is mixed with an acid while stirring.
In an artificial carrier production method in which the pH is adjusted to 2.5 to 6.0 and then an aldehyde-based crosslinking agent is applied to make it insolubilized, particles are generated by the addition of the acid and then the particle dispersion is cooled to below the gelation temperature. A method for producing an artificial carrier, characterized in that the crosslinking agent is allowed to act at a temperature below the gelation temperature.
JP20987181A 1981-03-18 1981-12-28 Manufacture of artificial carrier Granted JPS58113757A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP20987181A JPS58113757A (en) 1981-12-28 1981-12-28 Manufacture of artificial carrier
EP19820301235 EP0062968B2 (en) 1981-03-18 1982-03-11 Support material for use in serological testing and process for the production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20987181A JPS58113757A (en) 1981-12-28 1981-12-28 Manufacture of artificial carrier

Publications (2)

Publication Number Publication Date
JPS58113757A JPS58113757A (en) 1983-07-06
JPS6332150B2 true JPS6332150B2 (en) 1988-06-28

Family

ID=16580013

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20987181A Granted JPS58113757A (en) 1981-03-18 1981-12-28 Manufacture of artificial carrier

Country Status (1)

Country Link
JP (1) JPS58113757A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020067548A1 (en) * 2018-09-28 2020-04-02 Spiber株式会社 Fire-retardant protein molded body and production method for same

Also Published As

Publication number Publication date
JPS58113757A (en) 1983-07-06

Similar Documents

Publication Publication Date Title
Cortesi et al. Sugar cross-linked gelatin for controlled release: microspheres and disks
US5578709A (en) Macromolecular microparticles and methods of production
JPH06505961A (en) Ionically crosslinked polymer microcapsules
WO1996029059A9 (en) Microcapsules of predetermined peptide(s) specificity(ies), their preparation and uses
JPS6223826B2 (en)
DE69026024T2 (en) Artificial carrier for immobilizing biological proteins and process for its production
JPS6161062B2 (en)
CN103933012A (en) Modified gelatin capsule
JPH0317103B2 (en)
JPS5951355A (en) Reagent for detecting antiviral antibody
JPS60130601A (en) Manufacture of hyaluronic acid water-insoluble composition
JPH0317303B2 (en)
JPS6332150B2 (en)
EP0062968B2 (en) Support material for use in serological testing and process for the production thereof
JPS6332149B2 (en)
JPS6329223B2 (en)
JPS6332146B2 (en)
JPS6332147B2 (en)
JPS6348021B2 (en)
JPS6332148B2 (en)
RU2380708C1 (en) Method for making antibody test system for latex fixation test
RU2326655C1 (en) Method of incapsulation of protein bearing materials in microspheres from copolymer polylactide-polyglycolide
JPH05306113A (en) Artificial particle
JPH05126830A (en) Manufacturing method of immunological agglutination particle
JPH08105892A (en) Method for manufacturing immunodiagnostic reagent

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees
S199 Written request for registration of transfer of right

Free format text: JAPANESE INTERMEDIATE CODE: R313199

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370